8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2007 / Intervention trial with in vitro experiments
Volunteers were fed a high red meat or a vegetarian diet, and fecal and ileal samples were analyzed for nitrosyl iron, nitrosothiols, and heme, alongside in vitro gastric simulations. Nitrosyl iron and nitrosothiols were significantly increased in ileal and fecal samples following the high red meat diet compared with the vegetarian diet (p < 0.0001). Significantly more nitrosyl iron than nitrosothiols was present in ileal (p < 0.0001) and fecal (p < 0.001) samples. Fecal nitrosyl iron strongly correlated with heme (0.776; p < 0.0001), and ESR confirmed nitrosyl heme in feces after the high red meat diet.
Kuhnle GG, Story GW, Reda T, et al. Free Radic Biol Med, 2007. PMID 17761300
2007 / Intervention study (pre-post with working day control)
Twelve healthy male subjects participated in a 3-day/2-night trip across three forest fields, involving scheduled 2-hour walks, to investigate the effect of forest bathing on immune function. Measurements were compared to a baseline normal working day. Almost all subjects (11/12) showed higher NK activity after the trip (about 50 percent increased). The trip also significantly increased the numbers of NK cells and cells expressing perforin, granulysin, and granzymes A/B.
Li Q, Morimoto K, Nakadai A, et al. Int J Immunopathol Pharmacol, 2007. PMID 17903349
2007 / Intervention trial with animal and human components
Researchers evaluated the protective effects of topical sulforaphane-rich extracts of 3-day-old broccoli sprouts against UV radiation in mice and humans. In six human subjects (three males and three females, 28-53 years of age), the extract up-regulated phase 2 enzymes and achieved a mean reduction in erythema across six UVR doses (300-800 mJ/cm² in 100 mJ/cm² increments) of 37.7% (range 8.37-78.1%; P = 0.025).
Talalay P, Fahey JW, Healy ZR, et al. Proc Natl Acad Sci U S A, 2007. PMID 17956979
2006 / Dietary intervention studies (pooled analysis)
Fecal water samples were collected from 21 individuals across two studies who consumed diets containing varying amounts of red meat, protein, heme, and iron to assess genotoxicity using two Comet assay protocols. Fecal water genotoxicity showed no significant effect from diet (P > 0.20), mean transit time (P = 0.588), or weight (P = 0.705), but had a significant effect of age (P = 0.019). There was no significant correlation between fecal homogenate ATNC concentrations and fecal water genotoxicity (r = 0.04, P = 0.74). ATNC levels were significantly lower in fecal water (272 microg/kg) than in fecal homogenate (895 microg/kg) (P < 0.0001).
Cross AJ, Greetham HL, Pollock JR, et al. Environ Mol Mutagen, 2006. PMID 16304669
2006 / Double-blind, placebo-controlled trial
A double-blind, placebo-controlled study in healthy humans evaluated the urinary excretion of the carcinogen N-nitrososarcosine during creatine supplementation. Participants took a high dose of creatine (20 g/d) for one week followed by a low dose (5 g/d) for 20 weeks. Oral creatine ingestion did not systematically elevate urinary excretion of N-nitrososarcosine.
Derave W, Vanden Eede E, Hespel P, et al. Nutrition, 2006. PMID 16413752
2006 / Randomized controlled trial
A randomized double-blind trial tested daily administration of 600 mg green tea catechins versus placebo in 60 men with high-grade prostate intraepithelial neoplasia over 1 year. One tumor was diagnosed among 30 men receiving catechins (approximately 3% incidence) compared with 9 cancers among 30 men receiving placebo (30% incidence). International Prostate Symptom Scores also improved significantly in treated men with coexistent benign prostatic hyperplasia.
Bettuzzi S, Brausi M, Rizzi F, et al. Cancer Res, 2006. PMID 16424063
2006 / Randomized crossover trial
In a randomized crossover trial, human volunteers consumed high red meat (420 g), vegetarian, and high red meat plus high-fiber diets for 15 days in a controlled volunteer suite. In 21 volunteers, endogenous formation of apparent total N-nitrosocompounds (ATNC) in feces significantly increased on the red meat diet compared with the vegetarian diet (P < 0.0001). Colonic exfoliated cells showed a significantly higher percentage staining positive for O(6)-carboxymethyl guanine (O(6)CMG) adducts on the high red meat diet (P < 0.001), with intermediate levels in 13 volunteers on the high-fiber, high red meat diet. Fecal ATNC correlated positively with the percentage of O(6)CMG-positive cells (r(2) = 0.56, P = 0.011).
Lewin MH, Bailey N, Bandaletova T, et al. Cancer Res, 2006. PMID 16452248
2006 / Intervention feeding experiment and cross-sectional comparison
Researchers determined the salicylate content of commonly used spices, Indian cooked dishes, and blood and urine samples taken after ingestion of a test meal, while also measuring serum salicylic acid concentrations in villagers from southern India compared with typical European values. Salicylic acid was detected in all spices (up to 1.5 wt %) and cooked dishes. Blood and urine salicylate content increased following meal consumption, indicating bioavailability. Additionally, serum salicylic acid levels in rural Indians were significantly higher, with a median almost 3-fold higher than values previously measured in Western vegetarians.
Paterson JR, Srivastava R, Baxter GJ, et al. J Agric Food Chem, 2006. PMID 16608205
2006 / Phase II clinical trial
A phase II clinical trial evaluated daily intake of eight ounces of pomegranate juice in men with rising prostate-specific antigen following prostate cancer surgery or radiation. Treatment significantly increased average prostate-specific antigen doubling time from 15 months at baseline to 54 months posttreatment (p < 0.001). Patient serum also displayed decreased prostate cancer cell proliferation, increased apoptosis, and reduced lipid oxidation markers in laboratory assays.
Pantuck AJ, Leppert JT, Zomorodian N, et al. Clin Cancer Res, 2006. PMID 16818701
2006 / Before-and-after trial
A 6-month pre-post clinical trial examined a plant-based diet combined with stress management among 14 individuals with recurrent prostate cancer. The rate of prostate-specific antigen (PSA) rise was significantly lower during the intervention than prestudy (P < .01). Among 10 evaluable patients, four experienced absolute decreases in PSA levels, and nine had reduced rates of PSA rise, with median PSA doubling time lengthening from 11.9 months prestudy to 112.3 months during the study.
Saxe GA, Major JM, Nguyen JY, et al. Integr Cancer Ther, 2006. PMID 16880425
2006 / Before-and-after trial
In a 6-month pre-post pilot trial, recurrent prostate cancer patients adopted a plant-based diet with stress management. Median daily whole grain intake was 1.7 servings at baseline, 6.9 at 3 months, and 5.0 at 6 months; vegetable intake was 2.8, 5.0, and 4.8 servings, respectively. The rate of PSA rise decreased from the prestudy period (0.059) to 0-3 months (-0.002, P < .01), inversely tracking changes in plant-food consumption.
Nguyen JY, Major JM, Knott CJ, et al. Integr Cancer Ther, 2006. PMID 16880426
2006 / Intervention study
Overweight/obese postmenopausal women followed a low-fat (10-15% kcal), high-fiber (30-40 g per 1,000 kcal/day) diet and attended daily exercise classes for 2 weeks. Serum estradiol decreased in women on hormone treatment (n = 28) and those not on hormone treatment (n = 10), while serum insulin and IGF-I significantly decreased and IGF binding protein-1 increased across all women. Using subjects' serum in vitro, growth was reduced by 6.6% in MCF-7 cells, 9.9% in ZR-75-1 cells, and 18.5% in T-47D cells, while apoptosis increased by 20% in ZR-75-1, 23% in MCF-7, and 30% in T-47D cells (n = 12).
Barnard RJ, Gonzalez JH, Liva ME, et al. Nutr Cancer, 2006. PMID 16965238
2006 / Dietary intervention trial
Researchers examined the effect of a low-fat, high-carbohydrate (LFHC) dietary intervention on time to menopause in 2,611 premenopausal women with extensive mammographic density followed for an average of 7 years. The LFHC intervention did not affect the time to natural menopause overall (P = 0.72 for log-rank test; n = 699 events). An interaction between study group and baseline BMI was observed (P = 0.01), showing earlier menopause in the intervention group when BMI was low, and later menopause associated with higher BMI only in the intervention group. Greater parity, weight, and education were associated with later menopause, whereas older age at first birth and baseline smoking were associated with earlier menopause.
Martin LJ, Greenberg CV, Kriukov V, et al. Am J Clin Nutr, 2006. PMID 17023721
2006 / Randomized crossover trial (plus rat studies)
Researchers evaluated urinary 8-iso-PGF(2)alpha and DHN-MA across two rat studies and a randomized crossover human trial testing four diets (60 g/d red meat baseline, 120 g/d red meat, baseline with heme iron, and baseline with non-heme iron). In humans, the heme-supplemented diet led to a 2-fold increase in urinary DHN-MA (P < 0.001), while 8-iso-PGF(2)alpha did not increase. In rats, high-heme diets dramatically increased DHN-MA in parallel with preneoplastic lesions (P < 0.0001) and moderately increased 8-iso-PGF(2)alpha (P < 0.0001).
Pierre F, Peiro G, Taché S, et al. Cancer Epidemiol Biomarkers Prev, 2006. PMID 17119057
2006 / Randomized controlled trial
A randomized prospective trial assigned 2,437 women with resected early-stage breast cancer to a dietary fat-reduction intervention (n = 975) or control (n = 1,462). After a median follow-up of 60 months, fat intake was lower in the intervention group (33.3 vs. 51.3 g/day at 12 months; P < .001), alongside a 6-pound lower mean body weight (P = .005). Relapse events occurred in 9.8% of the intervention group and 12.4% of controls, corresponding to a hazard ratio of 0.76 (95% CI = 0.60 to 0.98; P = .077 for stratified log rank, P = .034 for adjusted Cox model).
Chlebowski RT, Blackburn GL, Thomson CA, et al. J Natl Cancer Inst, 2006. PMID 17179478
2006 / Randomized controlled trial
In the MeDiet Project, 115 healthy postmenopausal women were randomized to either an intervention group following a traditional, restricted Mediterranean diet (n = 58) or a control group continuing their regular diet (n = 57) for 6 months. Women in the intervention group shifted from prevalent intake of animal fat and proteins to vegetable fat and proteins. After 6 months, women in the intervention group showed a significant decrease of over 40% in total urinary estrogen levels (P < 0.02), primarily driven by marked decreases in hydroxy- and keto-derivatives of estradiol or estrone, while control women showed no major change.
Carruba G, Granata OM, Pala V, et al. Nutr Cancer, 2006. PMID 17474873
2005 / Phase I clinical trial
A phase I dose-escalation trial evaluated oral green tea extract in 17 patients with advanced lung cancer. The maximum tolerated dose was established at 3 g/m2 per day, with dose-limiting toxicities including nausea, diarrhea, and hypertension. No objective tumor responses occurred, though seven participants maintained stable disease for 4 to 16 weeks before progressing.
Laurie SA, Miller VA, Grant SC, et al. Cancer Chemother Pharmacol, 2005. PMID 15309507
2005 / Double-blind, randomized, placebo-controlled crossover trial
In a double-blind, randomized, placebo-controlled crossover trial, 64 postmenopausal women with a history of breast cancer took 114 mg of isolated isoflavonoids or placebo daily for 3 months, separated by a 2-month washout period. Isolated isoflavones did not relieve vaginal dryness. Vaginal maturation index values remained unchanged during isoflavone treatment but decreased during placebo. No changes were observed in any endometrial variables, including thickness, histology, estrogen and progesterone receptors, or Ki-67 expression.
Nikander E, Rutanen EM, Nieminen P, et al. Fertil Steril, 2005. PMID 15652899
2005 / Prospective clinical trial
Nineteen patients with hormone refractory prostate cancer received 250 mg green tea extract capsules twice daily in a prospective clinical trial. Of the 15 participants who finished at least 2 months of treatment, 9 showed progressive disease within 2 months. The remaining 6 individuals developed disease progression after an additional 1 to 4 months of therapy, demonstrating minimal clinical efficacy.
Choan E, Segal R, Jonker D, et al. Urol Oncol, 2005. PMID 15869995
2005 / Randomized double-blind placebo-controlled trial
Postmenopausal patients with newly diagnosed breast cancer were randomized to consume a 25 g flaxseed-containing muffin (n = 19) or a control placebo muffin (n = 13) daily between diagnosis and surgery. The flaxseed group showed significant reductions in Ki-67 labeling index (34.2%; P = 0.001) and c-erbB2 expression (71.0%; P = 0.003), along with an increase in apoptosis (30.7%; P = 0.007), which were not observed in the placebo group. Mean urinary lignan excretion increased by 1,300% (P < 0.01) in the flaxseed group compared with placebo. Total flaxseed intake correlated with changes in c-erbB2 score (r = -0.373; P = 0.036) and apoptotic index (r = 0.495; P < 0.004).
Thompson LU, Chen JM, Li T, et al. Clin Cancer Res, 2005. PMID 15897583
2005 / Randomized controlled trial
In a randomized double-blind trial, 83 evaluable patients with advanced, incurable breast or colorectal cancer received standard care combined with either a shark cartilage supplement or placebo three to four times daily. Shark cartilage did not improve overall survival compared with placebo. Furthermore, the intervention showed no benefit for quality of life, failing to demonstrate efficacy in this patient population.
Loprinzi CL, Levitt R, Barton DL, et al. Cancer, 2005. PMID 15912493
2005 / Randomized controlled trial
Ninety-three men with early, biopsy-proven prostate cancer who chose no conventional treatment were randomized to comprehensive lifestyle changes or a usual care control group for 1 year. None of the experimental group patients but 6 control patients underwent conventional treatment due to an increase in PSA or disease progression on MRI. PSA decreased 4% in the experimental group while increasing 6% in controls (p = 0.016). Serum from the experimental group inhibited LNCaP cell growth nearly 8 times more than control serum (70% vs. 9%, p < 0.001), and changes were significantly associated with the degree of lifestyle change.
Ornish D, Weidner G, Fair WR, et al. J Urol, 2005. PMID 16094059
2005 / 2-year randomized nutritional trial
In a 2-year randomized trial, 196 healthy premenopausal women consumed either two daily servings of soya foods (tofu, soya milk, soya nuts, or soya protein powder providing 50 mg isoflavones and 5-22 g soya protein per serving) or maintained their regular diet. Morning serum samples were collected at baseline, 3, 6, 12, and 24 months during the luteal phase. Researchers found no significant intervention effect on IGF-1, IGFBP-3, or their molar ratio across the entire study period. However, urinary isoflavone excretion during the study period was positively associated with IGF-1 (P=0.04) and the IGF-1:IGFBP-3 ratio (P=0.06).
Maskarinec G, Takata Y, Murphy SP, et al. Br J Nutr, 2005. PMID 16176606
2005 / Randomized crossover trial
A randomized crossover study evaluated the production of mammalian lignans in healthy postmenopausal women consuming food bars containing 25 g unground whole flaxseed (FB), sesame seed (SB), or a combination (FSB; 12.5 g each) for 4 weeks each, separated by 4-week washout periods. Urinary mammalian lignan excretion increased significantly with all treatments (65.1-81.0 mumol/day; P < 0.0001) with no significant differences among treatments. An unidentified lignan metabolite was detected following consumption of SB and FSB, but not FB.
Coulman KD, Liu Z, Hum WQ, et al. Nutr Cancer, 2005. PMID 16201847